Երիկամի քրոնիկ հիվանդություն (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Երիկամի քրոնիկ հիվանդություն" in Armenian language version.

refsWebsite

Global rank Armenian rank

73nih.gov

4^th place

3^rd place

48doi.org

2^nd place

4^th place

7archive.org

6^th place

5web.archive.org

1^st place

2handle.net

102^nd place

2,318^th place

2oxfordjournals.org

1,389^th place

284^th place

2medicc.org

low place

2nice.org.uk

3,258^th place

697^th place

1hopkinsmedicine.org

5,712^th place

2,105^th place

1medlineplus.gov

1,581^st place

470^th place

1kdigo.org

low place

9,471^st place

1google.ca

838^th place

113^th place

1medscape.com

719^th place

149^th place

1usrds.org

low place

1jamanetwork.com

2,650^th place

1,216^th place

1biomedcentral.com

2,747^th place

793^rd place

1hdcn.com

low place

1kidney.org

low place

4,646^th place

1worldcat.org

5^th place

10^th place

1creativecommons.org

1,010^th place

3,508^th place

1ahajournals.org

3,608^th place

1,018^th place

1asnjournals.org

low place

9,280^th place

1choosingwisely.org

7,197^th place

652^nd place

1ama-assn.org

3,257^th place

1,105^th place

1cdc.gov

218^th place

51^st place

1apho.org.uk

low place

1ajkdblog.org

low place

1icij.org

6,620^th place

7,011^th place

1slu.se

9,598^th place

low place

ahajournals.org

circ.ahajournals.org

Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW (2003 թ․ հոկտեմբեր). «Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention». Circulation. 108 (17): 2154–69. doi:10.1161/01.CIR.0000095676.90936.80. PMID 14581387.

ajkdblog.org

Tangri N (2013 թ․ հուլիսի 29). «MesoAmerican Nephropathy: A New Entity». eAJKD. National Kidney Foundation.

ama-assn.org

archinte.ama-assn.org

Appel LJ, Wright JT, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY (2008 թ․ ապրիլ). «Long-term effects of renin–angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans». Arch. Intern. Med. 168 (8): 832–39. doi:10.1001/archinte.168.8.832. PMC 3870204. PMID 18443258.(չաշխատող հղում)

apho.org.uk

Morgan T (2009 թ․ հունվարի 21). «Chronic Kidney Disease (stages 3–5) prevalence estimates using data from the Neoerica study (2007)». Association of Public Health Observatories. Արխիվացված է օրիգինալից 2011 թ․ հուլիսի 18-ին. Վերցված է 2019 թ․ փետրվարի 2-ին.

archive.org

Hruska KA, Mathew S, Lund R, Qiu P, Pratt R (2008). «Hyperphosphatemia of chronic kidney disease». Kidney Int. 74 (2): 148–57. doi:10.1038/ki.2008.130. PMC 2735026. PMID 18449174.
Bover J, Jara A, Trinidad P, Rodriguez M, Martin-Malo A, Felsenfeld AJ (1994). «The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia». Kidney Int. 46 (2): 310–17. doi:10.1038/ki.1994.276. PMID 7967341.
Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006). «Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)». Kidney Int. 69 (11): 1945–53. doi:10.1038/sj.ki.5000414. PMID 16641930.
Adrogué HJ, Madias NE (1981 թ․ սեպտեմբեր). «Changes in plasma potassium concentration during acute acid-base disturbances». Am. J. Med. 71 (3): 456–67. doi:10.1016/0002-9343(81)90182-0. PMID 7025622.
Vanholder, R; De Smet, R; Glorieux, G; Argilés, A; Baurmeister, U; Brunet, P; Clark, W; Cohen, G; De Deyn, PP; Deppisch, R; Descamps-Latscha, B; Henle, T; Jörres, A; Lemke, HD; Massy, ZA; Passlick-Deetjen, J; Rodriguez, M; Stegmayr, B; Stenvinkel, P; Tetta, C; Wanner, C; Zidek, W; European Uremic Toxin Work Group, (EUTox). (2003 թ․ մայիս). «Review on uremic toxins: classification, concentration, and interindividual variability». Kidney International. 63 (5): 1934–43. doi:10.1046/j.1523-1755.2003.00924.x. PMID 12675874.
Perazella MA, Khan S (2006 թ․ մարտ). «Increased mortality in chronic kidney disease: a call to action». Am. J. Med. Sci. 331 (3): 150–53. doi:10.1097/00000441-200603000-00007. PMID 16538076.
Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman DH (2013 թ․ նոյեմբեր). «The epidemic of chronic kidney disease of unknown etiology in Mesoamerica: a call for interdisciplinary research and action». Am J Public Health. 103 (11): 1927–30. doi:10.2105/AJPH.2013.301594. PMC 3828726. PMID 24028232.

asnjournals.org

jasn.asnjournals.org

Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (2006 թ․ հուլիս). «Chronic kidney disease and mortality risk: a systematic review». J. Am. Soc. Nephrol. 17 (7): 2034–47. doi:10.1681/ASN.2005101085. PMID 16738019.

biomedcentral.com

Redmon JH, Elledge MF, Womack DS, Wickremashinghe R, Wanigasuriya KP, Peiris-John RJ, Lunyera J, Smith K, Raymer JH, Levine KE (2014). «Additional perspectives on chronic kidney disease of unknown aetiology (CKDu) in Sri Lanka – lessons learned from the WHO CKDu population prevalence study». BMC Nephrology. 15 (1): 125. doi:10.1186/1471-2369-15-125. PMC 4120717. PMID 25069485.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)

cdc.gov

Centers for Disease Control Prevention (CDC) (2007 թ․ մարտ). «Prevalence of chronic kidney disease and associated risk factors—United States, 1999–2004». MMWR Morb. Mortal. Wkly. Rep. 56 (8): 161–65. PMID 17332726.

choosingwisely.org

American Society of Nephrology. «Five Things Physicians and Patients Should Question» (PDF). Choosing Wisely: An Initiative of the ABIM Foundation. Վերցված է 2012 թ․ օգոստոսի 17-ին.

creativecommons.org

Content initially copied from: Hansen, Kristoffer; Nielsen, Michael; Ewertsen, Caroline (2015). «Ultrasonography of the Kidney: A Pictorial Review». Diagnostics. 6 (1): 2. doi:10.3390/diagnostics6010002. ISSN 2075-4418. PMC 4808817. PMID 26838799.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link) (CC-BY 4.0)

doi.org

Liao, Min-Tser; Sung, Chih-Chien; Hung, Kuo-Chin; Wu, Chia-Chao; Lo, Lan; Lu, Kuo-Cheng (2012). «Insulin Resistance in Patients with Chronic Kidney Disease». Journal of Biomedicine and Biotechnology. 2012: 1–5. doi:10.1155/2012/691369. PMC 3420350. PMID 22919275.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
GBD 2015 Mortality and Causes of Death, Collaborators. (2016 թ․ հոկտեմբերի 8). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281. {{cite journal}}: |first1= has generic name (օգնություն)CS1 սպաս․ թվային անուններ: authors list (link)
«Summary of Recommendation Statements». Kidney International Supplement. 3 (1): 5–14. 2013 թ․ հունվար. doi:10.1038/kisup.2012.77. PMC 4284512. PMID 25598998.
GBD 2013 Mortality and Causes of Death, Collaborators (2014 թ․ դեկտեմբերի 17). «Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013». Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442. {{cite journal}}: |first1= has generic name (օգնություն)CS1 սպաս․ թվային անուններ: authors list (link) Table 2, p. 137
Hruska KA, Mathew S, Lund R, Qiu P, Pratt R (2008). «Hyperphosphatemia of chronic kidney disease». Kidney Int. 74 (2): 148–57. doi:10.1038/ki.2008.130. PMC 2735026. PMID 18449174.
Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M (2011). «FGF23 induces left ventricular hypertrophy». J Clin Invest. 121 (11): 4393–408. doi:10.1172/JCI46122. PMC 3204831. PMID 21985788.
Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M (2008). «Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis». N Engl J Med. 359 (6): 584–92. doi:10.1056/NEJMoa0706130. PMC 2890264. PMID 18687639.
Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, Adams JS, Salusky IB, Hewison M (2012 թ․ օգոստոս). «FGF23 inhibits extra-renal synthesis of 1,25-dihydroxyvitamin D in human monocytes». J Bone Miner Res. 28 (1): 46–55. doi:10.1002/jbmr.1740. PMC 3511915. PMID 22886720.
Bover J, Jara A, Trinidad P, Rodriguez M, Martin-Malo A, Felsenfeld AJ (1994). «The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia». Kidney Int. 46 (2): 310–17. doi:10.1038/ki.1994.276. PMID 7967341.
Brandenburg VM, Cozzolino M, Ketteler M (2011). «Calciphylaxis: a still unmet challenge». J. Nephrol. 24 (2): 142–48. doi:10.5301/jn.2011.6366. PMID 21337312.
Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006). «Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)». Kidney Int. 69 (11): 1945–53. doi:10.1038/sj.ki.5000414. PMID 16641930.
Adrogué HJ, Madias NE (1981 թ․ սեպտեմբեր). «Changes in plasma potassium concentration during acute acid-base disturbances». Am. J. Med. 71 (3): 456–67. doi:10.1016/0002-9343(81)90182-0. PMID 7025622.
Damman, Kevin; Valente, Mattia A. E.; Voors, Adriaan A.; O'Connor, Christopher M.; Veldhuisen, Dirk J. van; Hillege, Hans L. (2014 թ․ փետրվարի 14). «Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis». European Heart Journal. 35 (7): 455–69. doi:10.1093/eurheartj/eht386. PMID 24164864.
Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Saglimbene V, Ruospo M, Querques M, Jannini EA, Strippoli GF (2010). «Interventions for treating sexual dysfunction in patients with chronic kidney disease». Cochrane Database Syst Rev (12): CD007747. doi:10.1002/14651858.CD007747.pub2. PMID 21154382.
GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (2016 թ․ հոկտեմբերի 8). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282. {{cite journal}}: |first1= has generic name (օգնություն)CS1 սպաս․ թվային անուններ: authors list (link)
Rahman, Mahboob; Smith, Michael C. (1998 թ․ սեպտեմբեր). «Chronic renal insufficiency: A diagnostic and therapeutic approach». Archives of Internal Medicine. 158 (16): 1743–52. doi:10.1001/archinte.158.16.1743. PMID 9738603.
Redmon JH, Elledge MF, Womack DS, Wickremashinghe R, Wanigasuriya KP, Peiris-John RJ, Lunyera J, Smith K, Raymer JH, Levine KE (2014). «Additional perspectives on chronic kidney disease of unknown aetiology (CKDu) in Sri Lanka – lessons learned from the WHO CKDu population prevalence study». BMC Nephrology. 15 (1): 125. doi:10.1186/1471-2369-15-125. PMC 4120717. PMID 25069485.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Vanholder, R; De Smet, R; Glorieux, G; Argilés, A; Baurmeister, U; Brunet, P; Clark, W; Cohen, G; De Deyn, PP; Deppisch, R; Descamps-Latscha, B; Henle, T; Jörres, A; Lemke, HD; Massy, ZA; Passlick-Deetjen, J; Rodriguez, M; Stegmayr, B; Stenvinkel, P; Tetta, C; Wanner, C; Zidek, W; European Uremic Toxin Work Group, (EUTox). (2003 թ․ մայիս). «Review on uremic toxins: classification, concentration, and interindividual variability». Kidney International. 63 (5): 1934–43. doi:10.1046/j.1523-1755.2003.00924.x. PMID 12675874.
Yamamoto, Suguru; Kazama, Junichiro James; Wakamatsu, Takuya; Takahashi, Yoshimitsu; Kaneko, Yoshikatsu; Goto, Shin; Narita, Ichiei (2016 թ․ սեպտեմբերի 14). «Removal of uremic toxins by renal replacement therapies: a review of current progress and future perspectives». Renal Replacement Therapy. 2 (1). doi:10.1186/s41100-016-0056-9.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Qaseem A, Hopkins RH, Sweet DE, Starkey M, Shekelle P (2013 թ․ հոկտեմբերի 22). «Screening, Monitoring, and Treatment of Stage 1 to 4 Chronic Kidney Disease: A Clinical Practice Guideline From the Clinical Guidelines Committee of the American College of Physicians». Annals of Internal Medicine. 159 (12): 835–47. doi:10.7326/0003-4819-159-12-201312170-00726. PMID 24145991.
Weckmann, GFC; Stracke, S; Haase, A; Spallek, J; Ludwig, F; Angelow, A; Emmelkamp, JM; Mahner, M; Chenot, JF (2018 թ․ հոկտեմբերի 11). «Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines». BMC Nephrology. 19 (1): 258. doi:10.1186/s12882-018-1048-5. PMC 6180496. PMID 30305035.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Content initially copied from: Hansen, Kristoffer; Nielsen, Michael; Ewertsen, Caroline (2015). «Ultrasonography of the Kidney: A Pictorial Review». Diagnostics. 6 (1): 2. doi:10.3390/diagnostics6010002. ISSN 2075-4418. PMC 4808817. PMID 26838799.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link) (CC-BY 4.0)
Xie, X; Liu, Y; Perkovic, V; Li, X; Ninomiya, T; Hou, W; Zhao, N; Liu, L; Lv, J; Zhang, H; Wang, H (2015 թ․ նոյեմբեր). «Renin–Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials». American Journal of Kidney Diseases (Systematic Review & Meta-Analysis). S0272-6386 (15): 01312–8. doi:10.1053/j.ajkd.2015.10.011. PMID 26597926.
Malhotra, Rakesh; Nguyen, Hoang Anh; Benavente, Oscar; Mete, Mihriye; Howard, Barbara V.; Mant, Jonathan; Odden, Michelle C.; Peralta, Carmen A.; Cheung, Alfred K.; Nadkarni, Girish N.; Coleman, Ruth L.; Holman, Rury R.; Zanchetti, Alberto; Peters, Ruth; Beckett, Nigel; Staessen, Jan A.; Ix, Joachim H. (2017 թ․ սեպտեմբերի 5). «Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5». JAMA Internal Medicine. 177 (10): 1498–1505. doi:10.1001/jamainternmed.2017.4377. PMC 5704908. PMID 28873137.
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I (2001). «Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes». N Engl J Med. 345 (12): 851–60. doi:10.1056/NEJMoa011303. hdl:2445/122787. PMID 11565517.
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001). «Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy». N Engl J Med. 345 (12): 861–69. doi:10.1056/NEJMoa011161. hdl:2445/122643. PMID 11565518.
Chauhan V, Vaid M (2009 թ․ նոյեմբեր). «Dyslipidemia in chronic kidney disease: managing a high-risk combination». Postgrad Med. 121 (6): 54–61. doi:10.3810/pgm.2009.11.2077. PMID 19940417.
Kalantar-Zadeh K, Fouque D (2017 թ․ նոյեմբերի 2). «Nutritional management of chronic kidney disease». N. Engl. J. Med. 377 (18): 1765–1776. doi:10.1056/NEJMra1700312. PMID 29091561.
Locatelli F, Aljama P, Canaud B, Covic A, De Francisco A, Macdougall IC, Wiecek A, Vanholder R (2010 թ․ սեպտեմբեր). «Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study». Nephrol Dial Transplant. 25 (9): 2846–50. doi:10.1093/ndt/gfq336. PMID 20591813.
Clement FM, Klarenbach S, Tonelli M, Johnson JA, Manns BJ (2009 թ․ հունիսի 22). «The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis». Archives of Internal Medicine. 169 (12): 1104–12. doi:10.1001/archinternmed.2009.112. PMID 19546410.
Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, Burns K, Manns B, White C, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Jindal K, Senior P, Pannu N, Shurraw S, Akbari A, Cohn A, Reslerova M, Deved V, Mendelssohn D, Nesrallah G, Kappel J, Tonelli M (2008 թ․ նոյեմբեր). «Guidelines for the management of chronic kidney disease». CMAJ. 179 (11): 1154–62. doi:10.1503/cmaj.080351. PMC 2582781. PMID 19015566.
Yang, Q; Abudou, M; Xie, XS; Wu, T (2014 թ․ հոկտեմբերի 9). «Androgens for the anaemia of chronic kidney disease in adults». The Cochrane Database of Systematic Reviews. 10 (10): CD006881. doi:10.1002/14651858.CD006881.pub2. PMID 25300168.
Perazella MA, Khan S (2006 թ․ մարտ). «Increased mortality in chronic kidney disease: a call to action». Am. J. Med. Sci. 331 (3): 150–53. doi:10.1097/00000441-200603000-00007. PMID 16538076.
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW (2003 թ․ հոկտեմբեր). «Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention». Circulation. 108 (17): 2154–69. doi:10.1161/01.CIR.0000095676.90936.80. PMID 14581387.
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (2006 թ․ հուլիս). «Chronic kidney disease and mortality risk: a systematic review». J. Am. Soc. Nephrol. 17 (7): 2034–47. doi:10.1681/ASN.2005101085. PMID 16738019.
Heidenheim AP, Kooistra MP, Lindsay RM (2004). Quality of life. Contributions to Nephrology. Vol. 145. էջեր 99–105. doi:10.1159/000081673. ISBN 978-3-8055-7808-0. PMID 15496796. {{cite book}}: |journal= ignored (օգնություն)
de Francisco AL, Piñera C (2006 թ․ հունվար). «Challenges and future of renal replacement therapy». Hemodial Int. 10 (Suppl 1): S19–23. doi:10.1111/j.1542-4758.2006.01185.x. PMID 16441862.
Groothoff JW (2005 թ․ հուլիս). «Long-term outcomes of children with end-stage renal disease». Pediatr. Nephrol. 20 (7): 849–53. doi:10.1007/s00467-005-1878-9. PMID 15834618.
Giri M (2004). «Choice of renal replacement therapy in patients with diabetic end stage renal disease». Edtna Erca J. 30 (3): 138–42. doi:10.1111/j.1755-6686.2004.tb00353.x. PMID 15715116.
Pierratos A, McFarlane P, Chan CT (2005 թ․ մարտ). «Quotidian dialysis–update 2005». Curr. Opin. Nephrol. Hypertens. 14 (2): 119–24. doi:10.1097/00041552-200503000-00006. PMID 15687837.
Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P (1999). «Cancer in patients on dialysis for end-stage renal disease: An international collaborative study». Lancet. 354 (9173): 93–99. doi:10.1016/S0140-6736(99)06154-1. PMID 10408483.
Chertow GM, Paltiel AD, Owen WF, Lazarus JM (1996). «Cost-effectiveness of Cancer Screening in End-Stage Renal Disease». Archives of Internal Medicine. 156 (12): 1345–50. doi:10.1001/archinte.1996.00440110117016. PMID 8651845.
Appel LJ, Wright JT, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY (2008 թ․ ապրիլ). «Long-term effects of renin–angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans». Arch. Intern. Med. 168 (8): 832–39. doi:10.1001/archinte.168.8.832. PMC 3870204. PMID 18443258.(չաշխատող հղում)
Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J (1997). «End-stage renal disease in African-American and white men. 16-year MRFIT findings». JAMA. 277 (16): 1293–98. doi:10.1001/jama.1997.03540400043029. PMID 9109467.
Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman DH (2013 թ․ նոյեմբեր). «The epidemic of chronic kidney disease of unknown etiology in Mesoamerica: a call for interdisciplinary research and action». Am J Public Health. 103 (11): 1927–30. doi:10.2105/AJPH.2013.301594. PMC 3828726. PMID 24028232.
Johnson RJ, Sánchez-Lozada LG (2013 թ․ հոկտեմբեր). «Chronic kidney disease: Mesoamerican nephropathy – new clues to the cause». Nat Rev Nephrol. 9 (10): 560–61. doi:10.1038/nrneph.2013.174. PMID 23999393.
Roncal Jimenez CA, Ishimoto T, Lanaspa MA, Rivard CJ, Nakagawa T, Ejaz AA, Cicerchi C, Inaba S, Le M, Miyazaki M, Glaser J, Correa-Rotter R, González MA, Aragón A, Wesseling C, Sánchez-Lozada LG, Johnson RJ (2014 թ․ օգոստոս). «Fructokinase activity mediates dehydration-induced renal injury». Kidney Int. 86 (2): 294–302. doi:10.1038/ki.2013.492. PMC 4120672. PMID 24336030.
Pelander, L.; Ljungvall, I.; Egenvall, A.; Syme, H.; Elliott, J.; Häggström, J. (2015 թ․ մայիսի 4). «Incidence of and mortality from kidney disease in over 600,000 insured Swedish dogs». Veterinary Record. 176 (25): 656. doi:10.1136/vr.103059. PMID 25940343.

google.ca

books.google.ca

Ferri, Fred F. (2017). Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1 (անգլերեն). Elsevier Health Sciences. էջեր 294–295. ISBN 9780323529570.

handle.net

hdl.handle.net

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I (2001). «Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes». N Engl J Med. 345 (12): 851–60. doi:10.1056/NEJMoa011303. hdl:2445/122787. PMID 11565517.
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001). «Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy». N Engl J Med. 345 (12): 861–69. doi:10.1056/NEJMoa011161. hdl:2445/122643. PMID 11565518.

hdcn.com

Johnson, David (2011 թ․ մայիսի 2). «Chapter 4: CKD Screening and Management: Overview». In Daugirdas, John (ed.). Handbook of Chronic Kidney Disease Management. Lippincott Williams and Wilkins. էջեր 32–43. ISBN 978-1-58255-893-6.

hopkinsmedicine.org

«What is renal failure?». Johns Hopkins Medicine (անգլերեն). Վերցված է 2017 թ․ դեկտեմբերի 18-ին.

icij.org

Chavkin, Sasha; Greene, Ronnie (2011 թ․ դեկտեմբերի 12). «Thousands of sugar cane workers die as wealthy nations stall on solutions». International Consortium of Investigative Journalists. Վերցված է 2012 թ․ նոյեմբերի 26-ին.

jamanetwork.com

archinte.jamanetwork.com

Rahman, Mahboob; Smith, Michael C. (1998 թ․ սեպտեմբեր). «Chronic renal insufficiency: A diagnostic and therapeutic approach». Archives of Internal Medicine. 158 (16): 1743–52. doi:10.1001/archinte.158.16.1743. PMID 9738603.

kdigo.org

KDIGO: Kidney Disease Improving Global Outcomes (2009 թ․ օգոստոս). «KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)» (PDF). Kidney Int. 76 (Suppl 113). Արխիվացված է օրիգինալից (PDF) 2016 թ․ դեկտեմբերի 13-ին.

kidney.org

National Kidney Foundation (2002). «K/DOQI clinical practice guidelines for chronic kidney disease». Արխիվացված է օրիգինալից 2005 թ․ ապրիլի 15-ին. Վերցված է 2008 թ․ հունիսի 29-ին.

medicc.org

Orantes CM, Herrera R, Almaguer M, Brizuela EG, Núñez L, Alvarado NP, Fuentes EJ, Bayarre HD, Amaya JC, Calero DJ, Vela XF, Zelaya SM, Granados DV, Orellana P (2014). «Epidemiology of chronic kidney disease in adults of Salvadoran agricultural communities». MEDICC Rev. 16 (2): 23–30. PMID 24878646.

mediccreview.medicc.org

Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández CE, Bayarre H, Amaya JC, Calero DJ, Orellana P, Colindres RM, Velázquez ME, Núñez SG, Contreras VM, Castro BE (2011 թ․ հոկտեմբեր). «Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009» (PDF). MEDICC Rev. 13 (4): 14–22. PMID 22143603. Արխիվացված է օրիգինալից (PDF) 2016 թ․ մարտի 3-ին. Վերցված է 2019 թ․ փետրվարի 2-ին.

medlineplus.gov

«Kidney Failure». MedlinePlus (անգլերեն). Վերցված է 2017 թ․ նոյեմբերի 11-ին.

medscape.com

emedicine.medscape.com

«Chronic Kidney Disease». medscape. 2018 թ․ սեպտեմբերի 16. {{cite journal}}: Cite journal requires |journal= (օգնություն)

nice.org.uk

National Institute for Health and Clinical Excellence. Clinical guideline 73: Chronic kidney disease. London, 2008.

guidance.nice.org.uk

«Anaemia management in people with chronic kidney disease (CG114)». NICE Clinical Guideline. UK National Institute for Health and Care Excellence. 2011 թ․ փետրվար.

nih.gov

pubmed.ncbi.nlm.nih.gov

Liao, Min-Tser; Sung, Chih-Chien; Hung, Kuo-Chin; Wu, Chia-Chao; Lo, Lan; Lu, Kuo-Cheng (2012). «Insulin Resistance in Patients with Chronic Kidney Disease». Journal of Biomedicine and Biotechnology. 2012: 1–5. doi:10.1155/2012/691369. PMC 3420350. PMID 22919275.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
GBD 2015 Mortality and Causes of Death, Collaborators. (2016 թ․ հոկտեմբերի 8). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281. {{cite journal}}: |first1= has generic name (օգնություն)CS1 սպաս․ թվային անուններ: authors list (link)
«Summary of Recommendation Statements». Kidney International Supplement. 3 (1): 5–14. 2013 թ․ հունվար. doi:10.1038/kisup.2012.77. PMC 4284512. PMID 25598998.
GBD 2013 Mortality and Causes of Death, Collaborators (2014 թ․ դեկտեմբերի 17). «Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013». Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442. {{cite journal}}: |first1= has generic name (օգնություն)CS1 սպաս․ թվային անուններ: authors list (link) Table 2, p. 137
Hruska KA, Mathew S, Lund R, Qiu P, Pratt R (2008). «Hyperphosphatemia of chronic kidney disease». Kidney Int. 74 (2): 148–57. doi:10.1038/ki.2008.130. PMC 2735026. PMID 18449174.
Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M (2011). «FGF23 induces left ventricular hypertrophy». J Clin Invest. 121 (11): 4393–408. doi:10.1172/JCI46122. PMC 3204831. PMID 21985788.
Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M (2008). «Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis». N Engl J Med. 359 (6): 584–92. doi:10.1056/NEJMoa0706130. PMC 2890264. PMID 18687639.
Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, Adams JS, Salusky IB, Hewison M (2012 թ․ օգոստոս). «FGF23 inhibits extra-renal synthesis of 1,25-dihydroxyvitamin D in human monocytes». J Bone Miner Res. 28 (1): 46–55. doi:10.1002/jbmr.1740. PMC 3511915. PMID 22886720.
Bover J, Jara A, Trinidad P, Rodriguez M, Martin-Malo A, Felsenfeld AJ (1994). «The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia». Kidney Int. 46 (2): 310–17. doi:10.1038/ki.1994.276. PMID 7967341.
Brandenburg VM, Cozzolino M, Ketteler M (2011). «Calciphylaxis: a still unmet challenge». J. Nephrol. 24 (2): 142–48. doi:10.5301/jn.2011.6366. PMID 21337312.
Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006). «Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)». Kidney Int. 69 (11): 1945–53. doi:10.1038/sj.ki.5000414. PMID 16641930.
Adrogué HJ, Madias NE (1981 թ․ սեպտեմբեր). «Changes in plasma potassium concentration during acute acid-base disturbances». Am. J. Med. 71 (3): 456–67. doi:10.1016/0002-9343(81)90182-0. PMID 7025622.
Damman, Kevin; Valente, Mattia A. E.; Voors, Adriaan A.; O'Connor, Christopher M.; Veldhuisen, Dirk J. van; Hillege, Hans L. (2014 թ․ փետրվարի 14). «Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis». European Heart Journal. 35 (7): 455–69. doi:10.1093/eurheartj/eht386. PMID 24164864.
Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Saglimbene V, Ruospo M, Querques M, Jannini EA, Strippoli GF (2010). «Interventions for treating sexual dysfunction in patients with chronic kidney disease». Cochrane Database Syst Rev (12): CD007747. doi:10.1002/14651858.CD007747.pub2. PMID 21154382.
GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (2016 թ․ հոկտեմբերի 8). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282. {{cite journal}}: |first1= has generic name (օգնություն)CS1 սպաս․ թվային անուններ: authors list (link)
Rahman, Mahboob; Smith, Michael C. (1998 թ․ սեպտեմբեր). «Chronic renal insufficiency: A diagnostic and therapeutic approach». Archives of Internal Medicine. 158 (16): 1743–52. doi:10.1001/archinte.158.16.1743. PMID 9738603.
Redmon JH, Elledge MF, Womack DS, Wickremashinghe R, Wanigasuriya KP, Peiris-John RJ, Lunyera J, Smith K, Raymer JH, Levine KE (2014). «Additional perspectives on chronic kidney disease of unknown aetiology (CKDu) in Sri Lanka – lessons learned from the WHO CKDu population prevalence study». BMC Nephrology. 15 (1): 125. doi:10.1186/1471-2369-15-125. PMC 4120717. PMID 25069485.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Orantes CM, Herrera R, Almaguer M, Brizuela EG, Núñez L, Alvarado NP, Fuentes EJ, Bayarre HD, Amaya JC, Calero DJ, Vela XF, Zelaya SM, Granados DV, Orellana P (2014). «Epidemiology of chronic kidney disease in adults of Salvadoran agricultural communities». MEDICC Rev. 16 (2): 23–30. PMID 24878646.
Vanholder, R; De Smet, R; Glorieux, G; Argilés, A; Baurmeister, U; Brunet, P; Clark, W; Cohen, G; De Deyn, PP; Deppisch, R; Descamps-Latscha, B; Henle, T; Jörres, A; Lemke, HD; Massy, ZA; Passlick-Deetjen, J; Rodriguez, M; Stegmayr, B; Stenvinkel, P; Tetta, C; Wanner, C; Zidek, W; European Uremic Toxin Work Group, (EUTox). (2003 թ․ մայիս). «Review on uremic toxins: classification, concentration, and interindividual variability». Kidney International. 63 (5): 1934–43. doi:10.1046/j.1523-1755.2003.00924.x. PMID 12675874.
Qaseem A, Hopkins RH, Sweet DE, Starkey M, Shekelle P (2013 թ․ հոկտեմբերի 22). «Screening, Monitoring, and Treatment of Stage 1 to 4 Chronic Kidney Disease: A Clinical Practice Guideline From the Clinical Guidelines Committee of the American College of Physicians». Annals of Internal Medicine. 159 (12): 835–47. doi:10.7326/0003-4819-159-12-201312170-00726. PMID 24145991.
Weckmann, GFC; Stracke, S; Haase, A; Spallek, J; Ludwig, F; Angelow, A; Emmelkamp, JM; Mahner, M; Chenot, JF (2018 թ․ հոկտեմբերի 11). «Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines». BMC Nephrology. 19 (1): 258. doi:10.1186/s12882-018-1048-5. PMC 6180496. PMID 30305035.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Content initially copied from: Hansen, Kristoffer; Nielsen, Michael; Ewertsen, Caroline (2015). «Ultrasonography of the Kidney: A Pictorial Review». Diagnostics. 6 (1): 2. doi:10.3390/diagnostics6010002. ISSN 2075-4418. PMC 4808817. PMID 26838799.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link) (CC-BY 4.0)
Xie, X; Liu, Y; Perkovic, V; Li, X; Ninomiya, T; Hou, W; Zhao, N; Liu, L; Lv, J; Zhang, H; Wang, H (2015 թ․ նոյեմբեր). «Renin–Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials». American Journal of Kidney Diseases (Systematic Review & Meta-Analysis). S0272-6386 (15): 01312–8. doi:10.1053/j.ajkd.2015.10.011. PMID 26597926.
Malhotra, Rakesh; Nguyen, Hoang Anh; Benavente, Oscar; Mete, Mihriye; Howard, Barbara V.; Mant, Jonathan; Odden, Michelle C.; Peralta, Carmen A.; Cheung, Alfred K.; Nadkarni, Girish N.; Coleman, Ruth L.; Holman, Rury R.; Zanchetti, Alberto; Peters, Ruth; Beckett, Nigel; Staessen, Jan A.; Ix, Joachim H. (2017 թ․ սեպտեմբերի 5). «Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5». JAMA Internal Medicine. 177 (10): 1498–1505. doi:10.1001/jamainternmed.2017.4377. PMC 5704908. PMID 28873137.
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I (2001). «Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes». N Engl J Med. 345 (12): 851–60. doi:10.1056/NEJMoa011303. hdl:2445/122787. PMID 11565517.
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001). «Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy». N Engl J Med. 345 (12): 861–69. doi:10.1056/NEJMoa011161. hdl:2445/122643. PMID 11565518.
Chauhan V, Vaid M (2009 թ․ նոյեմբեր). «Dyslipidemia in chronic kidney disease: managing a high-risk combination». Postgrad Med. 121 (6): 54–61. doi:10.3810/pgm.2009.11.2077. PMID 19940417.
Kalantar-Zadeh K, Fouque D (2017 թ․ նոյեմբերի 2). «Nutritional management of chronic kidney disease». N. Engl. J. Med. 377 (18): 1765–1776. doi:10.1056/NEJMra1700312. PMID 29091561.
Locatelli F, Aljama P, Canaud B, Covic A, De Francisco A, Macdougall IC, Wiecek A, Vanholder R (2010 թ․ սեպտեմբեր). «Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study». Nephrol Dial Transplant. 25 (9): 2846–50. doi:10.1093/ndt/gfq336. PMID 20591813.
Clement FM, Klarenbach S, Tonelli M, Johnson JA, Manns BJ (2009 թ․ հունիսի 22). «The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis». Archives of Internal Medicine. 169 (12): 1104–12. doi:10.1001/archinternmed.2009.112. PMID 19546410.
Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, Burns K, Manns B, White C, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Jindal K, Senior P, Pannu N, Shurraw S, Akbari A, Cohn A, Reslerova M, Deved V, Mendelssohn D, Nesrallah G, Kappel J, Tonelli M (2008 թ․ նոյեմբեր). «Guidelines for the management of chronic kidney disease». CMAJ. 179 (11): 1154–62. doi:10.1503/cmaj.080351. PMC 2582781. PMID 19015566.
Yang, Q; Abudou, M; Xie, XS; Wu, T (2014 թ․ հոկտեմբերի 9). «Androgens for the anaemia of chronic kidney disease in adults». The Cochrane Database of Systematic Reviews. 10 (10): CD006881. doi:10.1002/14651858.CD006881.pub2. PMID 25300168.
Perazella MA, Khan S (2006 թ․ մարտ). «Increased mortality in chronic kidney disease: a call to action». Am. J. Med. Sci. 331 (3): 150–53. doi:10.1097/00000441-200603000-00007. PMID 16538076.
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW (2003 թ․ հոկտեմբեր). «Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention». Circulation. 108 (17): 2154–69. doi:10.1161/01.CIR.0000095676.90936.80. PMID 14581387.
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (2006 թ․ հուլիս). «Chronic kidney disease and mortality risk: a systematic review». J. Am. Soc. Nephrol. 17 (7): 2034–47. doi:10.1681/ASN.2005101085. PMID 16738019.
Heidenheim AP, Kooistra MP, Lindsay RM (2004). Quality of life. Contributions to Nephrology. Vol. 145. էջեր 99–105. doi:10.1159/000081673. ISBN 978-3-8055-7808-0. PMID 15496796. {{cite book}}: |journal= ignored (օգնություն)
de Francisco AL, Piñera C (2006 թ․ հունվար). «Challenges and future of renal replacement therapy». Hemodial Int. 10 (Suppl 1): S19–23. doi:10.1111/j.1542-4758.2006.01185.x. PMID 16441862.
Groothoff JW (2005 թ․ հուլիս). «Long-term outcomes of children with end-stage renal disease». Pediatr. Nephrol. 20 (7): 849–53. doi:10.1007/s00467-005-1878-9. PMID 15834618.
Giri M (2004). «Choice of renal replacement therapy in patients with diabetic end stage renal disease». Edtna Erca J. 30 (3): 138–42. doi:10.1111/j.1755-6686.2004.tb00353.x. PMID 15715116.
Pierratos A, McFarlane P, Chan CT (2005 թ․ մարտ). «Quotidian dialysis–update 2005». Curr. Opin. Nephrol. Hypertens. 14 (2): 119–24. doi:10.1097/00041552-200503000-00006. PMID 15687837.
Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P (1999). «Cancer in patients on dialysis for end-stage renal disease: An international collaborative study». Lancet. 354 (9173): 93–99. doi:10.1016/S0140-6736(99)06154-1. PMID 10408483.
Chertow GM, Paltiel AD, Owen WF, Lazarus JM (1996). «Cost-effectiveness of Cancer Screening in End-Stage Renal Disease». Archives of Internal Medicine. 156 (12): 1345–50. doi:10.1001/archinte.1996.00440110117016. PMID 8651845.
Appel LJ, Wright JT, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY (2008 թ․ ապրիլ). «Long-term effects of renin–angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans». Arch. Intern. Med. 168 (8): 832–39. doi:10.1001/archinte.168.8.832. PMC 3870204. PMID 18443258.(չաշխատող հղում)
Centers for Disease Control Prevention (CDC) (2007 թ․ մարտ). «Prevalence of chronic kidney disease and associated risk factors—United States, 1999–2004». MMWR Morb. Mortal. Wkly. Rep. 56 (8): 161–65. PMID 17332726.
Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J (1997). «End-stage renal disease in African-American and white men. 16-year MRFIT findings». JAMA. 277 (16): 1293–98. doi:10.1001/jama.1997.03540400043029. PMID 9109467.
Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman DH (2013 թ․ նոյեմբեր). «The epidemic of chronic kidney disease of unknown etiology in Mesoamerica: a call for interdisciplinary research and action». Am J Public Health. 103 (11): 1927–30. doi:10.2105/AJPH.2013.301594. PMC 3828726. PMID 24028232.
Johnson RJ, Sánchez-Lozada LG (2013 թ․ հոկտեմբեր). «Chronic kidney disease: Mesoamerican nephropathy – new clues to the cause». Nat Rev Nephrol. 9 (10): 560–61. doi:10.1038/nrneph.2013.174. PMID 23999393.
Roncal Jimenez CA, Ishimoto T, Lanaspa MA, Rivard CJ, Nakagawa T, Ejaz AA, Cicerchi C, Inaba S, Le M, Miyazaki M, Glaser J, Correa-Rotter R, González MA, Aragón A, Wesseling C, Sánchez-Lozada LG, Johnson RJ (2014 թ․ օգոստոս). «Fructokinase activity mediates dehydration-induced renal injury». Kidney Int. 86 (2): 294–302. doi:10.1038/ki.2013.492. PMC 4120672. PMID 24336030.
Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández CE, Bayarre H, Amaya JC, Calero DJ, Orellana P, Colindres RM, Velázquez ME, Núñez SG, Contreras VM, Castro BE (2011 թ․ հոկտեմբեր). «Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009» (PDF). MEDICC Rev. 13 (4): 14–22. PMID 22143603. Արխիվացված է օրիգինալից (PDF) 2016 թ․ մարտի 3-ին. Վերցված է 2019 թ․ փետրվարի 2-ին.
Pelander, L.; Ljungvall, I.; Egenvall, A.; Syme, H.; Elliott, J.; Häggström, J. (2015 թ․ մայիսի 4). «Incidence of and mortality from kidney disease in over 600,000 insured Swedish dogs». Veterinary Record. 176 (25): 656. doi:10.1136/vr.103059. PMID 25940343.

ncbi.nlm.nih.gov

Liao, Min-Tser; Sung, Chih-Chien; Hung, Kuo-Chin; Wu, Chia-Chao; Lo, Lan; Lu, Kuo-Cheng (2012). «Insulin Resistance in Patients with Chronic Kidney Disease». Journal of Biomedicine and Biotechnology. 2012: 1–5. doi:10.1155/2012/691369. PMC 3420350. PMID 22919275.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
GBD 2015 Mortality and Causes of Death, Collaborators. (2016 թ․ հոկտեմբերի 8). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281. {{cite journal}}: |first1= has generic name (օգնություն)CS1 սպաս․ թվային անուններ: authors list (link)
«Summary of Recommendation Statements». Kidney International Supplement. 3 (1): 5–14. 2013 թ․ հունվար. doi:10.1038/kisup.2012.77. PMC 4284512. PMID 25598998.
GBD 2013 Mortality and Causes of Death, Collaborators (2014 թ․ դեկտեմբերի 17). «Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013». Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442. {{cite journal}}: |first1= has generic name (օգնություն)CS1 սպաս․ թվային անուններ: authors list (link) Table 2, p. 137
Hruska KA, Mathew S, Lund R, Qiu P, Pratt R (2008). «Hyperphosphatemia of chronic kidney disease». Kidney Int. 74 (2): 148–57. doi:10.1038/ki.2008.130. PMC 2735026. PMID 18449174.
Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M (2011). «FGF23 induces left ventricular hypertrophy». J Clin Invest. 121 (11): 4393–408. doi:10.1172/JCI46122. PMC 3204831. PMID 21985788.
Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M (2008). «Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis». N Engl J Med. 359 (6): 584–92. doi:10.1056/NEJMoa0706130. PMC 2890264. PMID 18687639.
Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, Adams JS, Salusky IB, Hewison M (2012 թ․ օգոստոս). «FGF23 inhibits extra-renal synthesis of 1,25-dihydroxyvitamin D in human monocytes». J Bone Miner Res. 28 (1): 46–55. doi:10.1002/jbmr.1740. PMC 3511915. PMID 22886720.
GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (2016 թ․ հոկտեմբերի 8). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282. {{cite journal}}: |first1= has generic name (օգնություն)CS1 սպաս․ թվային անուններ: authors list (link)
Redmon JH, Elledge MF, Womack DS, Wickremashinghe R, Wanigasuriya KP, Peiris-John RJ, Lunyera J, Smith K, Raymer JH, Levine KE (2014). «Additional perspectives on chronic kidney disease of unknown aetiology (CKDu) in Sri Lanka – lessons learned from the WHO CKDu population prevalence study». BMC Nephrology. 15 (1): 125. doi:10.1186/1471-2369-15-125. PMC 4120717. PMID 25069485.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Weckmann, GFC; Stracke, S; Haase, A; Spallek, J; Ludwig, F; Angelow, A; Emmelkamp, JM; Mahner, M; Chenot, JF (2018 թ․ հոկտեմբերի 11). «Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines». BMC Nephrology. 19 (1): 258. doi:10.1186/s12882-018-1048-5. PMC 6180496. PMID 30305035.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Content initially copied from: Hansen, Kristoffer; Nielsen, Michael; Ewertsen, Caroline (2015). «Ultrasonography of the Kidney: A Pictorial Review». Diagnostics. 6 (1): 2. doi:10.3390/diagnostics6010002. ISSN 2075-4418. PMC 4808817. PMID 26838799.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link) (CC-BY 4.0)
Malhotra, Rakesh; Nguyen, Hoang Anh; Benavente, Oscar; Mete, Mihriye; Howard, Barbara V.; Mant, Jonathan; Odden, Michelle C.; Peralta, Carmen A.; Cheung, Alfred K.; Nadkarni, Girish N.; Coleman, Ruth L.; Holman, Rury R.; Zanchetti, Alberto; Peters, Ruth; Beckett, Nigel; Staessen, Jan A.; Ix, Joachim H. (2017 թ․ սեպտեմբերի 5). «Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5». JAMA Internal Medicine. 177 (10): 1498–1505. doi:10.1001/jamainternmed.2017.4377. PMC 5704908. PMID 28873137.
Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, Burns K, Manns B, White C, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Jindal K, Senior P, Pannu N, Shurraw S, Akbari A, Cohn A, Reslerova M, Deved V, Mendelssohn D, Nesrallah G, Kappel J, Tonelli M (2008 թ․ նոյեմբեր). «Guidelines for the management of chronic kidney disease». CMAJ. 179 (11): 1154–62. doi:10.1503/cmaj.080351. PMC 2582781. PMID 19015566.
Appel LJ, Wright JT, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY (2008 թ․ ապրիլ). «Long-term effects of renin–angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans». Arch. Intern. Med. 168 (8): 832–39. doi:10.1001/archinte.168.8.832. PMC 3870204. PMID 18443258.(չաշխատող հղում)
Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman DH (2013 թ․ նոյեմբեր). «The epidemic of chronic kidney disease of unknown etiology in Mesoamerica: a call for interdisciplinary research and action». Am J Public Health. 103 (11): 1927–30. doi:10.2105/AJPH.2013.301594. PMC 3828726. PMID 24028232.
Roncal Jimenez CA, Ishimoto T, Lanaspa MA, Rivard CJ, Nakagawa T, Ejaz AA, Cicerchi C, Inaba S, Le M, Miyazaki M, Glaser J, Correa-Rotter R, González MA, Aragón A, Wesseling C, Sánchez-Lozada LG, Johnson RJ (2014 թ․ օգոստոս). «Fructokinase activity mediates dehydration-induced renal injury». Kidney Int. 86 (2): 294–302. doi:10.1038/ki.2013.492. PMC 4120672. PMID 24336030.

niddk.nih.gov

«What Is Chronic Kidney Disease?». National Institute of Diabetes and Digestive and Kidney Diseases. 2017 թ․ հունիս. Վերցված է 2017 թ․ դեկտեմբերի 19-ին.
«Chronic Kidney Disease Tests & Diagnosis». National Institute of Diabetes and Digestive and Kidney Diseases. 2016 թ․ հոկտեմբեր. Վերցված է 2017 թ․ դեկտեմբերի 19-ին.
«Managing Chronic Kidney Disease». National Institute of Diabetes and Digestive and Kidney Diseases. 2016 թ․ հոկտեմբեր.
«Kidney Failure». National Institute of Diabetes and Digestive and Kidney Diseases. Վերցված է 2017 թ․ նոյեմբերի 11-ին.
«Anemia in Chronic Kidney Disease». National Institute of Diabetes and Digestive and Kidney Diseases. 2016 թ․ հուլիս. Վերցված է 2017 թ․ դեկտեմբերի 19-ին.
«Mineral & Bone Disorder in Chronic Kidney Disease». National Institute of Diabetes and Digestive and Kidney Diseases. 2015 թ․ նոյեմբեր. Վերցված է 2017 թ․ դեկտեմբերի 19-ին.

oxfordjournals.org

eurheartj.oxfordjournals.org

Damman, Kevin; Valente, Mattia A. E.; Voors, Adriaan A.; O'Connor, Christopher M.; Veldhuisen, Dirk J. van; Hillege, Hans L. (2014 թ․ փետրվարի 14). «Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis». European Heart Journal. 35 (7): 455–69. doi:10.1093/eurheartj/eht386. PMID 24164864.

ndt.oxfordjournals.org

Locatelli F, Aljama P, Canaud B, Covic A, De Francisco A, Macdougall IC, Wiecek A, Vanholder R (2010 թ․ սեպտեմբեր). «Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study». Nephrol Dial Transplant. 25 (9): 2846–50. doi:10.1093/ndt/gfq336. PMID 20591813.

slu.se

pub.epsilon.slu.se

Lena, Pelander, (2018). Chronic kidney disease in the dog (անգլերեն). ISBN 978-91-7760-208-8. Վերցված է 2018 թ․ հունիսի 8-ին.{{cite book}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link) CS1 սպաս․ հավելյալ կետադրություն (link)

usrds.org

«United States Renal Data System (USRDS)». Արխիվացված է օրիգինալից 2007 թ․ փետրվարի 13-ին.

web.archive.org

KDIGO: Kidney Disease Improving Global Outcomes (2009 թ․ օգոստոս). «KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)» (PDF). Kidney Int. 76 (Suppl 113). Արխիվացված է օրիգինալից (PDF) 2016 թ․ դեկտեմբերի 13-ին.
«United States Renal Data System (USRDS)». Արխիվացված է օրիգինալից 2007 թ․ փետրվարի 13-ին.
National Kidney Foundation (2002). «K/DOQI clinical practice guidelines for chronic kidney disease». Արխիվացված է օրիգինալից 2005 թ․ ապրիլի 15-ին. Վերցված է 2008 թ․ հունիսի 29-ին.
Morgan T (2009 թ․ հունվարի 21). «Chronic Kidney Disease (stages 3–5) prevalence estimates using data from the Neoerica study (2007)». Association of Public Health Observatories. Արխիվացված է օրիգինալից 2011 թ․ հուլիսի 18-ին. Վերցված է 2019 թ․ փետրվարի 2-ին.
Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández CE, Bayarre H, Amaya JC, Calero DJ, Orellana P, Colindres RM, Velázquez ME, Núñez SG, Contreras VM, Castro BE (2011 թ․ հոկտեմբեր). «Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009» (PDF). MEDICC Rev. 13 (4): 14–22. PMID 22143603. Արխիվացված է օրիգինալից (PDF) 2016 թ․ մարտի 3-ին. Վերցված է 2019 թ․ փետրվարի 2-ին.

worldcat.org

Content initially copied from: Hansen, Kristoffer; Nielsen, Michael; Ewertsen, Caroline (2015). «Ultrasonography of the Kidney: A Pictorial Review». Diagnostics. 6 (1): 2. doi:10.3390/diagnostics6010002. ISSN 2075-4418. PMC 4808817. PMID 26838799.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link) (CC-BY 4.0)